MOPBX
Price
$35.43
Change
+$0.10 (+0.28%)
Updated
Nov 13 closing price
VTSAX
Price
$144.14
Change
-$0.09 (-0.06%)
Updated
Nov 13 closing price
Ad is loading...

MOPBX vs VTSAX

Header iconMOPBX vs VTSAX Comparison
Open Charts MOPBX vs VTSAXBanner chart's image
NYLI WMC Enduring Capital
Price$35.43
Change+$0.10 (+0.28%)
VolumeN/A
CapitalizationN/A
Vanguard Total Stock Mkt Idx Adm
Price$144.14
Change-$0.09 (-0.06%)
VolumeN/A
CapitalizationN/A
MOPBX vs VTSAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MOPBX vs. VTSAX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MOPBX is a Buy and VTSAX is a Buy.

FUNDAMENTALS
Fundamentals
VTSAX has more cash in the bank: 1.73T vs. MOPBX (577M). VTSAX pays higher dividends than MOPBX: VTSAX (1.35) vs MOPBX (0.15). MOPBX was incepted earlier than VTSAX: MOPBX (26 years) vs VTSAX (24 years). MOPBX is a more actively managed with annual turnover of: 17.00 vs. VTSAX (2.00). MOPBX has a lower initial minimum investment than VTSAX: MOPBX (1000) vs VTSAX (3000). VTSAX annual gain was more profitable for investors over the last year : 33.39 vs. MOPBX (30.87). VTSAX return over 5 years is better than : 87.46 vs. MOPBX (54.64).
MOPBXVTSAXMOPBX / VTSAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence26 years24 years-
Gain YTD17.64924.89171%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets577M1.73T0%
Annual Yield % from dividends0.151.3511%
Returns for 1 year30.8733.3992%
Returns for 3 years5.4822.8224%
Returns for 5 years54.6487.4662%
Returns for 10 years96.09194.0750%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VERX50.580.83
+1.67%
Vertex
IT551.801.14
+0.21%
Gartner
PDFS31.88-0.95
-2.89%
PDF Solutions
KMDA6.06-0.21
-3.35%
Kamada Ltd
VRCA0.84-0.08
-8.37%
Verrica Pharmaceuticals